Table 3.
Outcome of MSSA Versus MRSA PJI Treated With DAIR
| Study | N Studiesa | N Patients | Pooled Success Rateb |
|---|---|---|---|
| MSSA PJI | 28 | 1381 | 60% |
| MRSA PJI | 26 | 416 | 58% |
| Hip MSSA PJI | 2 | 32 | 81% |
| Hip MRSA PJI | 1 | 12 | 92% |
| Knee MSSA PJI | 3 | 56 | 66% |
| Knee MRSA PJI | 3 | 78 | 64% |
Abbreviations: DAIR, debridement, antibiotics, and retention of the implant; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; PJI, prosthetic joint infection.
aPer category, studies were included if they reported specific or combined outcome for hip and/or knee MSSA and MRSA.
bBased on individual patient data.